Histone acylation

Show results for

Unknown (73)
Genomics (58)
Transcriptomics (37)
Proteomics (28)
Other (8)
Metabolomics (1)

Organisms

Homo sapiens (37)
Schizophyllum commune H4-8 (24)
Mycobacterium tuberculosis SP7 (24)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (24)
Oryza sativa Japonica Group (24)
Rabbit calicivirus (24)
Crotalus durissus terrificus (24)
Eriocheir sinensis (24)
Candidatus Endoriftia persephonae (24)
Mycobacterium tuberculosis SP10 (24)
Mycobacterium tuberculosis SP13 (24)
Cotesia typhae (24)
Mycobacterium tuberculosis SP22 (24)
Cepaea nemoralis (24)
Geobacillus kaustophilus HTA426 (24)
Enterobacter ludwigii (24)
Trichoderma asperellum CBS 433.97 (24)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (24)
Nakaseomyces glabratus (24)
Olea europaea (24)
Mumps virus strain Enders (24)
Chlamydomonas reinhardtii (24)
Mus musculus (14)
Aplysia californica (1)
Rattus norvegicus (1)
Danio rerio (1)
Arabidopsis thaliana (1)
Oryza sativa Japonica Group (1)
Escherichia coli (1)
Pichia kudriavzevii (1)

Organisms

Homo sapiens (28)
Mus musculus (7)
Escherichia coli (1)
mouse gut metagenome (1)
Oryza sativa Japonica Group (1)

Repository

ENA (44)
geo (40)
pride (24)
biostudies-arrayexpress (18)
iProX (3)
MassIVE (2)
GNPS (1)

Tissue

Cell culture (7)
Early embryonic cell (5)
Brain (3)
Leaf (3)
Liver (3)
Breast (2)
Cecum (1)
Breast cancer cell (1)
Seedling (1)
Breast cancer cell line (1)
Embryonic stem cell (1)
Macrophage (1)
Heart (1)
Whole body (1)
Spleen (1)
Hepatocyte (1)
Permanent cell line cell (1)
Kidney (1)
Colon (1)

Disease

Breast cancer (3)
Disease free (3)
Prediabetes syndrome (1)
Brain cancer (1)

Technology Type

Mass Spectrometry (24)
Shotgun proteomics (16)
Bottom-up proteomics (6)
Gel-based experiment (5)
Affinity purification coupled with mass spectrometry proteomics (2)
All-ion fragmentation (1)
SRM/MRM (1)
Data-dependent acquisition (1)
Top-down proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

Q Exactive (2)
Orbitrap Fusion (1)

Publication Date

2021 (15)
2023 (14)
2022 (10)
2026 (8)
2025 (8)
2024 (5)
2020 (5)
2011 (4)
2014 (3)
2010 (3)
2015 (2)
2013 (2)
2009 (2)
2018 (2)
2012 (1)
2004 (1)
2019 (1)

First Public Date

2026 (11)
2021 (9)
2022 (8)
2025 (5)
2023 (5)
2024 (3)
2020 (2)
2018 (1)

Classification

bacteria (1)

Modification

N6 (2)
1x(15)N labeled L-valine (1)
N6-dimethyl-L-lysine (1)
Not available (1)

Study type

Transcription profiling by array (14)
ChIP-seq (2)
ChIP-chip by tiling array (1)
RNA-seq of coding RNA (1)

Release Date

2021 (12)
2023 (10)
2018 (9)
2020 (7)
2024 (6)
2017 (6)
2015 (5)
2025 (5)
2014 (4)
2011 (4)
2019 (4)
2016 (4)
2013 (3)
2010 (3)
2009 (3)
2022 (3)
2012 (1)
2004 (1)
2026 (1)

Lab affiliation

Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Executive Editor, ACS Chemical Biology (2)
Department of Integrative and Structural Computational Biology, The Scripps Research Institute, La Jolla, CA (1)
Institute of Plant Science of Paris-Saclay (IPS2), CNRS, INRA, Université Paris-sud 11, Université Paris-Saclay, 91405 Orsay, France (1)
Ludwig-Maximilians-Universität München Biomedical Center Munich Molecular Biology Großhadernerstr. 9 82152 Planegg-Martinsried (1)
Dr. P.A. van Veelen LUMC Centre for Proteomics and Metabolomics Head Proteomics group (1)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Associate Editor, ACS Chemical Biology (1)
1Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China 2Academy of Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China 3Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China (1)
Program for Cancer and Cell Biology, Department of Human Anatomy, Histology and Embryology, and PKU International Cancer Institute, Peking University Health Science Center, #38 Xue Yuan Road, Beijing 100191, China. (1)
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China (1)
European Instutute of Oncology, Milan (1)
Universitat Rovira i Virgili, Department of Electronic Engineering, Tarragona, Spain (1)
Agronomy College, Henan Agricultural University, China (1)
University of Minnesota at Twin Cities (1)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Exceutive Editor, ACS Chemical Biology (lab head) (1)
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK. (1)
European Institute of Oncology (1)
School of Basic Medicine, Biomedical Research Institute, Hubei University of Medicine, Shiyan 442000, China (1)
Sun Yat-sen University (1)
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA (1)
University of Pennsylvania (1)
Jiangsu Key Laboratory of Crop Genetics and Physiology/ Key Laboratory of Plant Functional Genomics of the Ministry of Education/ Jiangsu Key Laboratory of Crop Genomics and Molecular Breeding, Agricultural College of Yangzhou University, Yangzhou 225009, China (1)
Shenyang Agricultural University (1)
European Institute of Oncology, Milan, Italy (1)

Previous page
1 / 21
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 21
Next page

Sort by:

Relevance

Page size

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution V

PRJNA688722 | ENA

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution VI

PRJNA688735 | ENA

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution VII

PRJNA728346 | ENA

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution I

PRJNA688520 | ENA

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution II

PRJNA688656 | ENA

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution III

PRJNA688701 | ENA

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution IV

PRJNA688707 | ENA

Improved Mass Spectrometry-based methods to study histone propionylation

Histone post-translational modifications (PTMs) have crucial roles in a multitude of cellular processes, their aberrant levels have been linked with numerous diseases, including cancer. Although histone PTM investigations have focused so far on methylations and acetylations, alternative long-chain a...

ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse)

2024-07-11 | PXD050362 | Pride

DAXX interacts with histone acylation in gene regulation

PRJNA715759 | ENA

Histone PTM profiling in breast cancer clinical samples

Although cancer was long considered a genetic disease, the contribution of epigenetics to various aspects of cancer biology is now being increasingly recognized. In particular, aberrations in the deposition and maintenance of histone post-translational modifications (PTMs) can result in the inapprop...

ORGANISM(S): Homo sapiens (Human)

2025-08-01 | PXD057150 | Pride

Breast cancer Histone post-translational modifications Epigenetics

Previous page
1 / 21
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 21
Next page

Sort by:

Relevance

Page size

205 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

First Public Date

Classification

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets